Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-031620)

Filing Details

Accession Number:: 0000899243-18-031620
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-21 18:08:59
Reporting Period:: 2018-12-21

Accepted Time:: 2018-12-21 18:08:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1160308	Savara Inc	SVRA	Pharmaceutical Preparations (2834)	841318182

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1703487	N Robert Neville	6836 Bee Cave Road, Building Iii Suite 200 Austin TX 78746	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-21	23,517	$6.38	498,028	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price is a weighted average purchase price. The purchase prices ranged from $6.22 to $6.51. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.